1. VERISYSE AND VERIFLEX PHAKIC IOLs FOR CORRECTION OF HIGH MYOPIA
Bojan Kozomara, Maja Bohac, Nikica Gabric
Eye Clinic “Svjetlost” Banja Luka, RS,
Bosnia-Herzegovina
University Eye Hospital “Svjetlost” Zagreb,
Croatia

2. AUTHORS HAVE NO FINANCIAL INTEREST!
Serbian Ophthalmology Congress, Zlatibor, 2013.

3. PURPOSE
Retrospective assesment on 485 myopic eyes who underwent implantation of Verisyse, and Veriflex in the last 36 months for comparison of visual and refractive results, endothelial cell count loss and patient satisfaction
Serbian Ophthalmology Congress, Zlatibor, 2013.

4. METHODS INDICATIONS CONTRAINDICATIONS
Myopia more than -10 D or cornea less than 480 μm
Astigmatism less than 2.5D
More than 2200 endothelial cells/mm2
Anterior chamber > 3.00 mm
CONTRAINDICATIONS
Less than 18 years of age
Glaucoma
Uveitis
Abnormal iris (peaked pupil, elevated iris margin)
Pregnancy
Diabetes
Serbian Ophthalmology Congress, Zlatibor, 2013.

5. VERISYSE PIOL
235 lenses implanted in myopic eyes in the past 36 months
Range of diopters:
19 eyes -3.00D to -6.00D
30 eyes -6.50D to -9.00D
44 eyes -9.50D to D
59 eyes D to D
37 eyes D to D
33 eyes D to D
13 eyes D to D
Follow up 1-36 months
Serbian Ophthalmology Congress, Zlatibor, 2013.

6. VERIFLEX PIOL
214 lenses implanted in myopic eyes in the past 36 months
Range of diopters:
12 eyes -2.00D to D
18 eyes -4.50D to -6.00D
36 eyes -6.50D to -8.00D
46 eyes -8.50D to D
56 eyes D to D
46 eyes D to D
Follow up 1-36 months
Serbian Ophthalmology Congress, Zlatibor, 2013.

7. Intraoperative complications
Positive vitreous pressure
Iris prolapse
Endothelial damage
Haemorrhage
Serbian Ophthalmology Congress, Zlatibor, 2013.

8. Postoperative complications
Verisyse
Veriflex
Increased IOP
4% (9 eyes)
3% (6 eyes)
High postop. astigmatism
0.5% (1 eye)
Decentration of IOL
2% (5 eyes)
Irregularity of pupil
Anterior capsule opacities
Serbian Ophthalmology Congress, Zlatibor, 2013.

9. RESULTS
Serbian Ophthalmology Congress, Zlatibor, 2013.

10. RESULTS
Serbian Ophthalmology Congress, Zlatibor, 2013.

11. RESULTS
Intraoperative endothelial cell loss was 4.42% for Verisyse and 6.13% for Veriflex group
Intraoperative diffrence in ECC loss is probably due to mechanism of implantation
After the initial loss yearly loss of endothelial cells is 0.97% in Verisyse and 0.93% for Veriflex group
Serbian Ophthalmology Congress, Zlatibor, 2013.

12. CONCLUSION Satisfying results with all two types of lenses
Verysise IOL is most suitable with price and diopter range, but has large incision and sometimes requires other types of anesthesia than just topical
Veriflex IOL has the most matherial problems, the hardest to implant, sometimes requires other types of anesthesia than just topical.
Serbian Ophthalmology Congress, Zlatibor, 2013.

13. Thank you for your attention!